Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection-Reference-Cited by-同舟云学术

Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection

Published:2021-11-12 Issue:2 Volume:42 Page:320-329
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Kim Si Ho¹,Cho Eun Ju²,Jang Boo‐ok¹^ORCID,Lee Kyunghan¹,Choi Jae Kyun¹,Choi Gwang Hyeon¹,Lee Jeong‐Hoon²^ORCID,Yu Su Jong²^ORCID,Kim Yoon Jun²^ORCID,Lee Yun Bin²,Yoon Jeong‐Hwan²,Kim Jin‐Wook¹^ORCID,Jeong Sook‐Hyang¹^ORCID,Jang Eun Sun¹^ORCID

Affiliation:

1. Department of Internal Medicine Seoul National University College of Medicine Seoul National University Bundang Hospital Seongnam Republic of Korea

2. Department of Internal Medicine Seoul National University College of Medicine Seoul National University Hospital Seoul Republic of Korea

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15086

Reference30 articles.

1. World Health Organization.Hepatitis B Fact Sheet N204: Hepatitis B. WHO web site.https://www.who.int/en/news‐room/fact‐sheets/detail/hepatitis‐b. Accessed 30 Apr 2021

2. Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics;Yc H;Gastroenterol,2017

3. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

4. Hepatocellular carcinoma: a global view

5. Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis;Journal of Viral Hepatitis;2024-04-08

2. Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B;Gut and Liver;2024-01-12

3. Comparative Impact of TDF and ETV on the Prognosis of HCC Patients with Concurrent MASLD and HBV Infection after Hepatectomy;2023-12-08

4. Predictors of treatment efficacy with nucleos(t)ide analogues for chronic hepatitis B;Experimental and Clinical Gastroenterology;2023-07-26

5. Is nonalcoholic fatty liver disease a predictor of treatment response in chronic hepatitis B?;Journal of Medical Virology;2023-03